231 related articles for article (PubMed ID: 15252191)
21. Effect of low-dose theophylline on airway inflammation in COPD.
Kobayashi M; Nasuhara Y; Betsuyaku T; Shibuya E; Tanino Y; Tanino M; Takamura K; Nagai K; Hosokawa T; Nishimura M
Respirology; 2004 Jun; 9(2):249-54. PubMed ID: 15182277
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis of peripheral blood neutrophils in COPD exacerbation does not correlate with serum cytokines.
Schmidt-Ioanas M; Pletz MW; de Roux A; Lode H
Respir Med; 2006 Apr; 100(4):639-47. PubMed ID: 16199149
[TBL] [Abstract][Full Text] [Related]
23. Long-term clarithromycin in cystic fibrosis: effects on inflammatory markers in BAL and clinical status.
Doğru D; Dalgiç F; Kiper N; Ozçelik U; Yalçin E; Aslan AT; Gürcan N; Saricaoğlu F; Gür D; Karayazgan Y; Firat P
Turk J Pediatr; 2009; 51(5):416-23. PubMed ID: 20112595
[TBL] [Abstract][Full Text] [Related]
24. Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis.
Yalçin E; Kiper N; Ozçelik U; Doğru D; Firat P; Sahin A; Ariyürek M; Mocan G; Gürcan N; Göçmen A
J Clin Pharm Ther; 2006 Feb; 31(1):49-55. PubMed ID: 16476120
[TBL] [Abstract][Full Text] [Related]
25. Evaluating the profile of selected cytokines in patients with food allergy and chronic gastritis.
Bartuzi Z; Zbikowska-Gotz M; Romański B; Sinkiewicz W
Med Sci Monit; 2000; 6(6):1128-35. PubMed ID: 11208468
[TBL] [Abstract][Full Text] [Related]
26. In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients.
Panichi V; Paoletti S; Mantuano E; Manca-Rizza G; Filippi C; Santi S; Taccola D; Donadio C; Tramonti G; Innocenti M; Casto G; Consani C; Sbragia G; Franzoni F; Galetta F; Panicucci E; Barsotti G
Nephrol Dial Transplant; 2006 Feb; 21(2):337-44. PubMed ID: 16249194
[TBL] [Abstract][Full Text] [Related]
27. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
28. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
[TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory effect of methoxyphenamine compound in rat model of chronic obstructive pulmonary disease.
Wang YH; Bai CX; Hong QY; Chen J
Acta Pharmacol Sin; 2003 Dec; 24(12):1324-7. PubMed ID: 14653967
[TBL] [Abstract][Full Text] [Related]
30. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
[TBL] [Abstract][Full Text] [Related]
31. Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related.
Reid DW; Wen Y; Johns DP; Williams TJ; Ward C; Walters EH
Respirology; 2008 Nov; 13(6):799-809. PubMed ID: 18811878
[TBL] [Abstract][Full Text] [Related]
32. Longitudinal follow-up of systemic inflammation after acute exacerbations of COPD.
Groenewegen KH; Dentener MA; Wouters EF
Respir Med; 2007 Nov; 101(11):2409-15. PubMed ID: 17644367
[TBL] [Abstract][Full Text] [Related]
33. [Efficacy of a complementary antiinflammatory treatment with erespal in chronic obstructive and nonobstructive bronchitis].
Volkova LI; Budkova AA; Filonova NN; Khristoliubova EI; Kutuzova EB; Koroleva NV; Radzivil TT; Aminova ZR; Chuchalin AG
Ter Arkh; 2004; 76(8):51-6. PubMed ID: 15471398
[TBL] [Abstract][Full Text] [Related]
34. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum.
Vernooy JH; Küçükaycan M; Jacobs JA; Chavannes NH; Buurman WA; Dentener MA; Wouters EF
Am J Respir Crit Care Med; 2002 Nov; 166(9):1218-24. PubMed ID: 12403691
[TBL] [Abstract][Full Text] [Related]
35. Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease.
John M; Bosse S; Oltmanns U; Schumacher A; Witt C
Respir Med; 2005 Nov; 99(11):1418-24. PubMed ID: 15894479
[TBL] [Abstract][Full Text] [Related]
36. Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.
Chen YG; Xu F; Zhang Y; Ji QS; Sun Y; Lü RJ; Li RJ
Chin Med J (Engl); 2006 Jan; 119(1):32-6. PubMed ID: 16454979
[TBL] [Abstract][Full Text] [Related]
37. Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD.
Montuschi P; Macagno F; Parente P; Valente S; Lauriola L; Ciappi G; Kharitonov SA; Barnes PJ; Ciabattoni G
Thorax; 2005 Oct; 60(10):827-33. PubMed ID: 16192367
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.
Sethi S; Wrona C; Eschberger K; Lobbins P; Cai X; Murphy TF
Am J Respir Crit Care Med; 2008 Mar; 177(5):491-7. PubMed ID: 18079493
[TBL] [Abstract][Full Text] [Related]
39. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
[TBL] [Abstract][Full Text] [Related]
40. Levamisole can modulate the serum tumor necrosis factor-alpha level in patients with recurrent aphthous ulcerations.
Sun A; Wang JT; Chia JS; Chiang CP
J Oral Pathol Med; 2006 Feb; 35(2):111-6. PubMed ID: 16430742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
